SecProbe.io

Filing text and metadata
Intelligence Terminal Search Topics Monthly Activity About

SEC Comment Letter 0000000000-23-013801 to NewGenIvf Group Ltd (NIVF)

NewGenIvf Group Ltd
Date: Dec. 18, 2023 · CIK: 0001981662 · Accession: 0000000000-23-013801

AI Filing Summary & Sentiment

Sentiment
Urgency
Document Type
Confidence
SEC Posture
Company Posture

Summary

Reasoning

File numbers found in text: 333-275208

Date
December 18, 2023
Author
Claudius Tsang
Form
UPLOAD
Company
NewGenIvf Group Ltd

Letter

United States securities and exchange commission logo December 18, 2023 Claudius Tsang Chief Executive Officer and Chief Financial Officer A SPAC I Mini Acquisition Corp. Level 39, Marina Bay Financial Centre Tower 2, 10 Marina Boulevard Singapore, 018983 Re:A SPAC I Mini Acquisition Corp. Amendment No. 2 to Registration Statement on Form F-4 Filed December 7, 2023 File No. 333-275208 Dear Claudius Tsang: We have reviewed your amended registration statement and have the following comments. Please respond to this letter by amending your registration statement and providing the requested information. If you do not believe a comment applies to your facts and circumstances or do not believe an amendment is appropriate, please tell us why in your response. After reviewing any amendment to your registration statement and the information you provide in response to this letter, we may have additional comments. Unless we note otherwise, any references to prior comments are to comments in our November 28, 2023 letter. Amendment No. 2 to Registration Statement on Form F-4/A Cover Page 1.Please provide further information regarding the Additional Closing Shares, the decision to include the shares in the Second Amendment to the Merger Agreement, and state how the parties agreed on the $8mm value. Additionally, your disclosure says "[t]he aggregate consideration for the Business Combination is $50,000,000, payable in the form of 5,000,000 newly issued PubCo Class A ordinary shares valued at $10.00 per share to NewGenIvf’s shareholders, plus additional PubCo Class A ordinary shares in exchange for the NewGenIvf shares issued by NewGenIvf following the original date of the Merger Agreement (the “Additional Closing Shares”)." We also note that the definition of Additional Shares in the Second Amendment is "the Company Shares issued by the Company following the date of this Agreement (i.e., February 15, 2023)." It appears that it

FirstName LastNameClaudius Tsang Comapany NameA SPAC I Mini Acquisition Corp. December 18, 2023 Page 2 FirstName LastName Claudius Tsang A SPAC I Mini Acquisition Corp. December 18, 2023 Page 2 is currently contemplated that 800,000 Additional Closing Shares will be issued based on the amount shown in certain tables. Please revise your disclosure to clarify if this amount or value of shares is set or whether additional shares may be issued. Exhibits 2.We note your legal opinions, filed as Exhibits 5.1 and 5.2, are incomplete. Please file complete legal opinions, to include coverage of the Second Amendment to the Merger Agreement and the Additional Closing Shares to be issued. Please contact Michael Fay at 202-551-3812 or Al Pavot at 202-551-3738 if you have questions regarding comments on the financial statements and related matters. Please contact Benjamin Richie at 202-551-7857 or Margaret Schwartz at 202-551-7153 with any other questions. Sincerely, Division of Corporation Finance Office of Industrial Applications and Services cc: Giovanni Caruso, Esq.

Show Raw Text
United States securities and exchange commission logo
December 18, 2023
Claudius Tsang
Chief Executive Officer and Chief Financial Officer
A SPAC I Mini Acquisition Corp.
Level 39, Marina Bay Financial Centre
Tower 2, 10 Marina Boulevard
Singapore, 018983
Re:A SPAC I Mini Acquisition Corp.
Amendment No. 2 to Registration Statement on Form F-4
Filed December 7, 2023
File No. 333-275208
Dear Claudius Tsang:
            We have reviewed your amended registration statement and have the following
comments.
            Please respond to this letter by amending your registration statement and providing the
requested information. If you do not believe a comment applies to your facts and circumstances
or do not believe an amendment is appropriate, please tell us why in your response.
            After reviewing any amendment to your registration statement and the information you
provide in response to this letter, we may have additional comments. Unless we note otherwise,
any references to prior comments are to comments in our November 28, 2023 letter.
Amendment No. 2 to Registration Statement on Form F-4/A
Cover Page
1.Please provide further information regarding the Additional Closing Shares, the decision
to include the shares in the Second Amendment to the Merger Agreement, and state how
the parties agreed on the $8mm value. Additionally, your disclosure says "[t]he aggregate
consideration for the Business Combination is $50,000,000, payable in the form of
5,000,000 newly issued PubCo Class A ordinary shares valued at $10.00 per share to
NewGenIvf’s shareholders, plus additional PubCo Class A ordinary shares in exchange
for the NewGenIvf shares issued by NewGenIvf following the original date of the Merger
Agreement (the “Additional Closing Shares”)." We also note that the definition of
Additional Shares in the Second Amendment is "the Company Shares issued by the
Company following the date of this Agreement (i.e., February 15, 2023)." It appears that it

 FirstName LastNameClaudius Tsang
 Comapany NameA SPAC I Mini Acquisition Corp.
 December 18, 2023 Page 2
 FirstName LastName
Claudius Tsang
A SPAC I Mini Acquisition Corp.
December 18, 2023
Page 2
is currently contemplated that 800,000 Additional Closing Shares will be issued based on
the amount shown in certain tables. Please revise your disclosure to clarify if this amount
or value of shares is set or whether additional shares may be issued.
Exhibits
2.We note your legal opinions, filed as Exhibits 5.1 and 5.2, are incomplete. Please file
complete legal opinions, to include coverage of the Second Amendment to the Merger
Agreement and the Additional Closing Shares to be issued.
            Please contact Michael Fay at 202-551-3812 or Al Pavot at 202-551-3738 if you have
questions regarding comments on the financial statements and related matters. Please contact
Benjamin Richie at 202-551-7857 or Margaret Schwartz at 202-551-7153 with any other
questions.
Sincerely,
Division of Corporation Finance
Office of Industrial Applications and
Services
cc:       Giovanni Caruso, Esq.